{
  "ptid_time": "128_S_0188_2008-03-11",
  "img_path": "/data/qiuhui/data/adni/images/128_S_0188/2008-03-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 54,191 mm³, 15.3% above the reference mean. With a Z-score of 0.44 (67.1th percentile), this represents normal volume ; whole brain volume measures 1,100,310 mm³, 6.9% above the reference mean. With a Z-score of 0.91 (81.7th percentile), this represents normal volume . ",
  "text_data": "Age is 88.1 years. Gender is Male. Education: 16 years. MMSE: 28.0. Logical Memory: 9.0. Laboratory findings: Monocytes: 0.65 (significant elevated); Eosinophils: 0.36 (significant elevated); Platelets: 368.00 (significant elevated); Serum Glucose: 194.00 (profound elevated); Creatine Kinase: 205.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Pittsburgh compound B: 1.75 SUVR (normal ); Amyloid beta: 703.70 pg/mL (normal ); Total tau: 529.90 pg/mL (profound elevated); Phosphorylated tau: 57.62 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient has normal brain volumes (ventricular and whole brain) and normal Aβ levels, but **profoundly elevated T-tau and P-tau**, which strongly suggests neurodegeneration consistent with Alzheimer’s pathology. Despite the high MMSE (28/30), the tau biomarkers indicate significant neuronal injury.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (given biomarker evidence of tauopathy but preserved cognitive function near-normal range).  \n\n**Confidence:** **High** (due to clear tau elevation despite normal Aβ and MMSE, suggesting early-stage AD pathology).  \n\n*(Note: If cognitive symptoms were more pronounced, this could progress to dementia, but current MMSE suggests MCI.)*",
  "timestamp": "2025-07-26T13:35:41.643499"
}